Dirithromycin Delayed-Release Tablets

This is a preview of
USP-NF/PF content.

Subscriber?
Access here! Not a subscriber?
Learn more!

» Dirithromycin Delayed-Release Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of dirithromycin (C₄₂H₇₈N₂O₁₄), consisting of the 16R- and 16S-epimers.

USP REFERENCE STANDARDS FOR PURCHASE

USP Dirithromycin RS

This is a preview of
USP-NF/PF content.

Subscriber?
Access here!Not a subscriber?
Learn more!